Literature DB >> 19585573

Use of an expanded gold standard to estimate the accuracy of colposcopy and visual inspection with acetic acid.

A J Cagle1, S Y Hu, J W Sellors, Y P Bao, J M Lim, S M Li, K Lewis, Y Song, J F Ma, Q J Pan, W H Zhang, F H Zhao, Y L Qiao.   

Abstract

We estimate the accuracy of colposcopy and visual inspection with acetic acid (VIA) while minimizing the effects of misclassification bias, and maximizing ascertainment of disease. VIA was performed by experienced physicians on a population-based sample of women aged 30 to 49 years in rural Shanxi province, China. Each woman received VIA, liquid-based cytology (LBC) and hybrid capture 2 (hc2, QIAGEN, Gaithersburg, MD; formerly Digene Corporation). Any woman who tested positive on any test had colposcopy, endocervical curettage (ECC) with directed biopsies as necessary and 4-quadrant random biopsies from normal-appearing areas of the cervix. A standard diagnosis based on colposcopy and directed biopsy, and an expanded diagnosis including ECC and 4-quadrant random biopsy were generated for each woman. In 1,839 women, use of the expanded versus the standard diagnostic criteria increased the prevalence of histologically confirmed high-grade cervical intraepithelial neoplasia and cancer (CIN2+) from 3.2% (59/1,839) to 4.2% (77/1,839) and decreased the sensitivity of VIA for CIN2+ from 69.5% (95% CI: 56.8-79.8) to 58.4% (95% CI: 47.3-68.8%) with little change in specificity of approximately 89%. Compared with the expanded diagnostic criterion, the sensitivity of a visual diagnosis of high-grade CIN or cancer by a colposcopist was 49.4% (95% CI: 38.2-60.5). The use of an expanded diagnostic criterion in this study yielded more conservative estimates of the sensitivity of VIA and colposcopy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19585573     DOI: 10.1002/ijc.24719

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  16 in total

1.  Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China.

Authors:  Fang-Hui Zhao; Margaret Jane Lin; Feng Chen; Shang-Ying Hu; Rong Zhang; Jerome L Belinson; John W Sellors; Silvia Franceschi; You-Lin Qiao; Philip E Castle
Journal:  Lancet Oncol       Date:  2010-11-11       Impact factor: 41.316

2.  Evaluation of hybrid algorithm for analysis of scattered light using ex vivo nuclear morphology measurements of cervical epithelium.

Authors:  Derek Ho; Tyler K Drake; Rex C Bentley; Fidel A Valea; Adam Wax
Journal:  Biomed Opt Express       Date:  2015-07-07       Impact factor: 3.732

Review 3.  Clinical application of DNA ploidy to cervical cancer screening: A review.

Authors:  David Garner
Journal:  World J Clin Oncol       Date:  2014-12-10

4.  Pooled analysis of the performance of liquid-based cytology in population-based cervical cancer screening studies in China.

Authors:  Qin-Jing Pan; Shang-ying Hu; Xun Zhang; Pu-wa Ci; Wen-hua Zhang; Hui-qin Guo; Jian Cao; Fang-hui Zhao; Alice Lytwyn; You-lin Qiao
Journal:  Cancer Cytopathol       Date:  2013-04-23       Impact factor: 5.284

5.  Effectiveness of VIA, Pap, and HPV DNA testing in a cervical cancer screening program in a peri-urban community in Andhra Pradesh, India.

Authors:  Patti E Gravitt; Proma Paul; Hormuzd A Katki; Haripriya Vendantham; Gayatri Ramakrishna; Mrudula Sudula; Basany Kalpana; Brigitte M Ronnett; K Vijayaraghavan; Keerti V Shah
Journal:  PLoS One       Date:  2010-10-28       Impact factor: 3.240

6.  A population-based study of visual inspection with acetic acid (VIA) for cervical screening in rural Nigeria.

Authors:  Kayode Olusegun Ajenifuja; Julia C Gage; Akinfolarin C Adepiti; Nicolas Wentzensen; Claire Eklund; Mary Reilly; Martha Hutchinson; Robert D Burk; Mark Schiffman
Journal:  Int J Gynecol Cancer       Date:  2013-03       Impact factor: 3.437

Review 7.  CROI 2013: Complications of HIV disease, viral hepatitis, and antiretroviral therapy.

Authors:  Anne F Luetkemeyer; Diane V Havlir; Judith S Currier
Journal:  Top Antivir Med       Date:  2013 Apr-May

8.  Costs of cervical cancer screening and treatment using visual inspection with acetic acid (VIA) and cryotherapy in Ghana: the importance of scale.

Authors:  Wilm Quentin; Yaw Adu-Sarkodie; Fern Terris-Prestholt; Rosa Legood; Baafuor K Opoku; Philippe Mayaud
Journal:  Trop Med Int Health       Date:  2011-01-09       Impact factor: 2.622

9.  Asia oceania guidelines for the implementation of programs for cervical cancer prevention and control.

Authors:  Hextan Y S Ngan; Suzanne M Garland; Neerja Bhatla; Sonia R Pagliusi; Karen K L Chan; Annie N Y Cheung; Tang-Yuan Chu; Efren J Domingo; You Lin Qiao; Jong Sup Park; Eng Hseon Tay; Wisit Supakarapongkul
Journal:  J Cancer Epidemiol       Date:  2011-04-13

10.  Accuracy of Colposcopically Directed Biopsy: Results from an Online Quality Assurance Programme for Colposcopy in a Population-Based Cervical Screening Setting in Italy.

Authors:  Mario Sideri; Paola Garutti; Silvano Costa; Paolo Cristiani; Patrizia Schincaglia; Priscilla Sassoli de Bianchi; Carlo Naldoni; Lauro Bucchi
Journal:  Biomed Res Int       Date:  2015-06-09       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.